Manufacturing & Analytical Characterization
Anna Jenks (she/her/hers)
Director, Pharmaceutical Operations
Merck & Co., Inc. - Rahway NJ, New Jersey
A review of current flexible manufacturing capital projects at Merck including the new FLEX Facility for drug product clinical manufacturing and the MACS Facility for modality agnostic drug substance clinical manufacturing.
To view all Prologues, visit our library here and click "Enroll".